These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 9731491)
1. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer. Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds. Nnane IP; Kato K; Liu Y; Long BJ; Lu Q; Wang X; Ling YZ; Brodie A Endocrinology; 1999 Jun; 140(6):2891-7. PubMed ID: 10342882 [TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis. Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750 [TBL] [Abstract][Full Text] [Related]
4. Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo. Nnane IP; Njar VC; Liu Y; Lu Q; Brodie AM J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):145-52. PubMed ID: 10659703 [TBL] [Abstract][Full Text] [Related]
5. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line. Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094 [TBL] [Abstract][Full Text] [Related]
6. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046 [TBL] [Abstract][Full Text] [Related]
7. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract. George FW Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585 [TBL] [Abstract][Full Text] [Related]
8. LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5 alpha-reductase, and produces prostatic regression in male rats. Neubauer BL; Best KL; Blohm TR; Gates C; Goode RL; Hirsch KS; Laughlin ME; Petrow V; Smalstig EB; Stamm NB Prostate; 1993; 23(3):181-99. PubMed ID: 8234065 [TBL] [Abstract][Full Text] [Related]
9. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase. Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumour effects and pharmacokinetic profile of 17-(5'-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesis. Nnane IP; Long BJ; Ling YZ; Grigoryev DN; Brodie AM Br J Cancer; 2000 Jul; 83(1):74-82. PubMed ID: 10883671 [TBL] [Abstract][Full Text] [Related]
11. Effects of novel 17alpha-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo. Haidar S; Ehmer PB; Barassin S; Batzl-Hartmann C; Hartmann RW J Steroid Biochem Mol Biol; 2003 Apr; 84(5):555-62. PubMed ID: 12767280 [TBL] [Abstract][Full Text] [Related]
12. CGP 53153: a new potent inhibitor of 5alpha-reductase. Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628 [TBL] [Abstract][Full Text] [Related]
13. 4-pregnene-3-one-20 beta-carboxaldehyde: a potent inhibitor of 17 alpha-hydroxylase/C17,20-lyase and of 5 alpha-reductase. Li J; Li Y; Son C; Banks P; Brodie A J Steroid Biochem Mol Biol; 1992 May; 42(3-4):313-20. PubMed ID: 1606043 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone. Dadras SS; Cai X; Abasolo I; Wang Z Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528 [TBL] [Abstract][Full Text] [Related]
15. Novel nonsteroidal inhibitor of cytochrome P450(17alpha) (17alpha-hydroxylase/C17-20 lyase), YM116, decreased prostatic weights by reducing serum concentrations of testosterone and adrenal androgens in rats. Ideyama Y; Kudoh M; Tanimoto K; Susaki Y; Nanya T; Nakahara T; Ishikawa H; Yoden T; Okada M; Fujikura T; Akaza H; Shikama H Prostate; 1998 Sep; 37(1):10-8. PubMed ID: 9721064 [TBL] [Abstract][Full Text] [Related]
16. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor. di Salle E; Giudici D; Radice A; Zaccheo T; Ornati G; Nesi M; Panzeri A; Délos S; Martin PM J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):179-86. PubMed ID: 9605412 [TBL] [Abstract][Full Text] [Related]
17. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs. Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194 [TBL] [Abstract][Full Text] [Related]
18. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Bartsch G; Rittmaster RS; Klocker H Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of androgen synthesis by 22-hydroximino-23,24-bisnor-4-cholen-3-one. Li J; Li Y; Son C; Brodie AM Prostate; 1995 Mar; 26(3):140-50. PubMed ID: 7534917 [TBL] [Abstract][Full Text] [Related]
20. Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat. di Salle E; Giudici D; Biagini L; Cominato C; Briatico G; Panzeri A J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):381-5. PubMed ID: 7626485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]